Immunoassay Market - 2024-2033

April 2025 | 243 pages | ID: IF5C4E6FEE58EN
DataM Intelligence

Abstracts

The Immunoassay Market was valued at US$ 36.87 billion in 2024 and is anticipated to reach US$ 68.60 billion by 2033, at a CAGR of 0.071 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Immunoassay Market.

This report delivers a comprehensive overview of the Immunoassay Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunoassay Market. The Immunoassay Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

Immunoassay Market Scope:

Key Players

• Beckman Coulter, Inc.

Major Highlights

This report delivers a comprehensive overview of the Immunoassay Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunoassay Market. The Immunoassay Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2024–2033.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. MARKET INTRODUCTION AND SCOPE

1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope

2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS

3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS

3.1. Key Trends and Future Projections

4. SNIPPET BY TYPE

4.1. Snippet by Product Type
4.2. Snippet by Specimen
4.3. Snippet by Application
4.4. Snippet by End-User
4.5. Snippet by Region

5. DYNAMICS

5.1. Impacting Factors
  5.1.1. Drivers
    5.1.1.1. Increasing Innovation and Launches of Advanced Immunoassay Instruments
    5.1.1.2. Rising Prevalence of Chronic & Infectious Diseases
    5.1.1.3. XX
  5.1.2. Restraints
    5.1.2.1. The High Cost of Instruments & Reagents
    5.1.2.2. Complex Assay Procedures
    5.1.2.3. XX
  5.1.3. Opportunity
    5.1.3.1. Increasing Research and Development
    5.1.3.2. XX
  5.1.4. Impact Analysis

6. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK

6.1. Market Leaders and Pioneers
  6.1.1. Emerging Pioneers and Prominent Players
  6.1.2. Established leaders with the largest-selling Brand
  6.1.3. Market leaders with established Product
6.2. CXO Perspectives
6.3. Latest Developments and Breakthroughs
6.4. Case Studies/Ongoing Research
6.5. Regulatory and Reimbursement Landscape
  6.5.1. North America
  6.5.2. Europe
  6.5.3. Asia Pacific
  6.5.4. South America
  6.5.5. Middle East & Africa
6.6. Porter’s Five Force Analysis
6.7. Supply Chain Analysis
6.8. Patent Analysis
6.9. SWOT Analysis
6.10. Unmet Needs and Gaps
6.11. Recommended Strategies for Market Entry and Expansion
6.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
6.13. Pricing Analysis and Price Dynamics
6.14. Key Opinion Leaders

7. IMMUNOASSAY MARKET, BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type
7.2. ELISA*
  7.2.1. Introduction
  7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Radioimmunoassay (RIA)
7.4. Fluorescence Immunoassays (FIA)
7.5. Chemiluminescence Immunoassays (CLIA)
7.6. Rapid Assays
7.7. Others

8. IMMUNOASSAY MARKET, BY PRODUCT TYPE

8.1. Introduction
  8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  8.1.2. Market Attractiveness Index, By Product Type
8.2. Reagents & kits*
  8.2.1. Introduction
  8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  8.2.3. ELISA Reagents & Kits
  8.2.4. Rapid Test Reagents & Kits
  8.2.5. ELISPOT Reagents & Kits
  8.2.6. Western Blot Reagents & Kits
  8.2.7. Others
8.3. Analyzers
  8.3.1. Open-ended Systems
  8.3.2. Closed-ended Systems
8.4. Software & Services

9. IMMUNOASSAY MARKET, BY SPECIMEN

9.1. Introduction
  9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  9.1.2. Market Attractiveness Index, By Specimen
9.2. Blood*
  9.2.1. Introduction
  9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)

10. SALIVA

10.1. Urine
10.2. Other

11. IMMUNOASSAY MARKET, BY APPLICATION

11.1. Introduction
  11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  11.1.2. Market Attractiveness Index, By Application
11.2. Therapeutic Drug Monitoring*
  11.2.1. Introduction
  11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Drug Discovery
11.4. Disease Diagnosis
  11.4.1. Infectious Disease
  11.4.2. Cancer
  11.4.3. Endocrinology
  11.4.4. Autoimmune Disorders
  11.4.5. Cardiology
  11.4.6. Hematology
  11.4.7. Others
11.5. Other

12. IMMUNOASSAY MARKET, BY END-USER

12.1. Introduction
  12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  12.1.2. Market Attractiveness Index, By End-User
12.2. Hospitals*
  12.2.1. Introduction
  12.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
12.3. Blood Banks
12.4. Clinical Laboratories
12.5. Pharmaceutical and Biotech Companies
12.6. Academic Research Centers
12.7. Others

13. IMMUNOASSAY MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES

13.1. Introduction
  13.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    13.1.1.1. Market Attractiveness Index, By Region
13.2. North America
  13.2.1. Introduction
  13.2.2. Key Region-Specific Dynamics
  13.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.2.8.1. U.S
    13.2.8.2. Canada
    13.2.8.3. Mexico
13.3. Europe
  13.3.1. Introduction
  13.3.2. Key Region-Specific Dynamics
  13.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.3.8.1. Germany
    13.3.8.2. U.K.
    13.3.8.3. France
    13.3.8.4. Spain
    13.3.8.5. Italy
    13.3.8.6. Rest of Europe
13.4. South America
  13.4.1. Introduction
  13.4.2. Key Region-Specific Dynamics
  13.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.4.8.1. Brazil
    13.4.8.2. Argentina
    13.4.8.3. Rest of South America
13.5. Asia-Pacific
  13.5.1. Introduction
  13.5.2. Key Region-Specific Dynamics
  13.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
  13.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    13.5.8.1. China
    13.5.8.2. India
    13.5.8.3. Japan
    13.5.8.4. South Korea
    13.5.8.5. Rest of Asia-Pacific
13.6. Middle East and Africa
  13.6.1. Introduction
  13.6.2. Key Region-Specific Dynamics
  13.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
  13.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  13.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Specimen
  13.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  13.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

14. COMPETITIVE LANDSCAPE AND MARKET POSITIONING

14.1. Competitive Overview and Key Market Players
  14.1.1. Market Share Analysis and Positioning Matrix
  14.1.2. Strategic Partnerships, Mergers & Acquisitions
  14.1.3. Key Developments in Product Portfolios and Innovations
  14.1.4. Company Benchmarking

15. COMPANY PROFILES

15.1. Beckman Coulter, Inc.*
  15.1.1. Company Overview
  15.1.2. Product Portfolio
    15.1.2.1. Product Description
    15.1.2.2. Product Key Performance Indicators (KPIs)
    15.1.2.3. Historic and Forecasted Product Sales
    15.1.2.4. Product Sales Volume

16. FINANCIAL OVERVIEW

16.1. Company Revenue
  16.1.1. Geographical Revenue Shares
    16.1.1.1. Revenue Forecasts
  16.1.2. Key Developments
    16.1.2.1. Mergers & Acquisitions
    16.1.2.2. Key Product Development Activities
    16.1.2.3. Regulatory Approvals, etc.
  16.1.3. SWOT Analysis
16.2. F. Hoffmann-La Roche Ltd
16.3. Siemens Healthineers AG
16.4. BioM?rieux SA
16.5. Bio-Rad Laboratories, Inc
16.6. Abbott
16.7. DiaSorin S.p.A.
16.8. BD
16.9. Thermo Fisher Scientific Inc.
16.10. Merck KGaA (LIST NOT EXHAUSTIVE)

17. ASSUMPTION AND RESEARCH METHODOLOGY

17.1. Data Collection Methods
17.2. Data Triangulation
17.3. Forecasting Techniques
17.4. Data Verification and Validation

18. APPENDIX

18.1. About Us and Services
18.2. Contact Us